biotech

TL;DR * Iovance Biotherapeutics reports $86.7M Q4 revenue, 50% gross margin on FDA-approved T-cell therapy Amtagvi * Ascend Capital Partners raises $791M for second healthcare private equity fund targeting provider services and IT platforms * Wayve secures £1.01 billion funding from Microsoft, NVIDIA, and Uber to deploy zero-shot autonomous driving